patient reporting update
play

Patient reporting update Franois Houez Director of Treatment - PowerPoint PPT Presentation

Mar 02, 2024 •177 likes •476 views

Patient reporting update Franois Houez Director of Treatment Information & Access, E URORDIS 8 th Pharmacovigilance stakeholders forum EMA, 15/06/2014 15/09/2014 eurordis.org eurordis.org 1 Spontaneous reporting in EEA * (data

  1. Patient reporting update François Houÿez Director of Treatment Information & Access, E URORDIS 8 th Pharmacovigilance stakeholders’ forum EMA, 15/06/2014 15/09/2014 eurordis.org eurordis.org 1

  2. Spontaneous reporting in EEA * (data provided by EMA) 295,043 281,357 300,000 226,513 250,000 200,000 150,000 100,000 50,000 0 Pre Legislation After Legislation After Legislation 02/07/11 - 01/07/12 02/07/12 - 01/07/13 02/07/13 - 01/07/14 * Number of ICSRs received in EudraVigilance before de-duplication eurordis.org 2

  3. Spontaneous reporting by patients in EEA * 35,642 33,292 40,000 35,000 30,000 20,560 25,000 20,000 15,000 10,000 5,000 0 Pre Legislation After Legislation After Legislation 02/07/11 - 01/07/12 02/07/12 - 01/07/13 02/07/13 - 01/07/14 * Number of ICSRs received in EudraVigilance before de-duplication eurordis.org 3

  4. Spontaneous reporting by patients in EEA * Split by country: N ◦ reports by 1M population 400 350 If all EU citizens would report as much as the 300 Dutch do, this would represent 250 170 000 reports per year! 200 150 100 50 0 NL SE BE GB DK AT DE IS IT IE FI GR NO FR PT LU MT HR HU CZ PL ES EE SI CY SK LV LT BG RO LI Pre Legislation After Legislation After Legislation 02/07/11 - 01/07/12 02/07/12 - 01/07/13 02/07/13 - 01/07/14 * Number of ICSRs received in EudraVigilance before de-duplication eurordis.org 4

  5. Top 15 reactions reported by HCP or non-HCP adapted from EMA 5 6 3 10 Severity: does it match? 9 8 2 7 4 1 15/09/2014 eurordis.org 5

  6. ADR reporting tools as of May 2012 On-line reporting form Printed form No information available Non-EU/EEA other than CH eurordis.org 6

  7. ADR reporting tools as of April 2014 On-line reporting form Printed form No information available Non-EU/EEA other than CH eurordis.org 7

  8. HOW HELPFUL ARE THESE TOOLS? For some: 6 clicks to find the form… eurordis.org 8

  9. 15 choices 15/09/2014 eurordis.org 9

  10. As proposed 24 June 2010 (after release of Google Goggle) Med App checks moles for irregularities in size, shape, colour and border eurordis.org 10

  11. Does everyone know ? Puzzling what subcutaneous 63 Batch number. means as opposed to chara What’s this? intradermal? cters What if ADR occurs after 6 months of treatment 6, but in the Humm… How during which the patient alternatively took the elderly: average do I add a sheet originator product or a generic or a second generic? 10 medicines. to a pdf? e.g. loose tools and ricin oil as excipient in the generic 15/09/2014 eurordis.org 11

  12. Croatia – dose 15/09/2014 eurordis.org 12

  13. Publicising self-reporting 15/09/2014 eurordis.org 13

  14. 2003 Stem cell transp. (expired) 15/09/2014 eurordis.org 14

  15. 2006 Pompe’s 15/09/2014 eurordis.org 15

  16. 2007 Epilepsy 15/09/2014 eurordis.org 16

  17. 2008 Multiple myeloma 15/09/2014 eurordis.org 17

  18. 2005 HIV 15/09/2014 eurordis.org 18

  19. Withdrawn obesity 15/09/2014 eurordis.org 19

  20. Corroborates PhWP recommendation Including 6 CS Signal 15/09/2014 eurordis.org 20

  21. PRAC Rodin/PedNet study corroborated by ADR reports 15/09/2014 eurordis.org 21

  22.  ? eurordis.org 22

  23.  2006 MS 15/09/2014 eurordis.org 23

  24.  2011 HIV 15/09/2014 eurordis.org 24

  25.  2012 cystic fib. 15/09/2014 eurordis.org 25

  26.  2012 Keratosis 15/09/2014 eurordis.org 26

  27.  2012 Meningitis meningoc. 15/09/2014 eurordis.org 27

  28. Spontaneous reporting by patients in EEA * Top 15 Substances 0 200 400 600 800 1,000 1,200 Etanercept 1,096 Adalimumab 810 767 Interferon Beta-1A Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) 606 Levonorgestrel 601 Rivaroxaban 599 591 Measles, Mumps And Rubella Vaccine (Live) Diphtheria, Tetanus, Pertussis (Acellular, Component), Hepatitis B (Rdna), Poliomyelitis 543 (Inact.) And Haemophilus Type B Conjugate Vaccine (Adsorbed) Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) 502 Vaccine (Adsorbed) Human Papillomavirus Vaccine 466 431 Carbidopa, Levodopa Amoxicillin, Clavulanic Acid 387 Metformin 375 Diclofenac 370 345 Influenza Vaccine (Split Virion, Inactivated) * Number of ICSRs received in EudraVigilance before de-duplication – Period: 02/ 07/ 13 - 01/ 07/ 14 eurordis.org 28

  29. Conclusions • Eudravigilance = a live database, not a cemetery of data • Patient reporting and active involvement of patients in pharmacovigilance: a reality • www.adrreports.eu informs on where more efforts can be invested: – Understanding the drivers of patient reporting • Specific research by disease area, by MS,  or not, orphan or not, drug authorised ante/post 2012, delays MA- first reports… – May help targeting the communication on reporting tools – May help in defining appropriate measures as defined in article 102 Pharmacovigilance Directive – Be curious: look for the drugs in your own disease area! 15/09/2014 eurordis.org 29

Recommend

Patient reporting in EudraVigilance a measure of patient engagement? Workshop on measuring the

Patient reporting in EudraVigilance a measure of patient engagement? Workshop on measuring the

Patient reporting in EudraVigilance a measure of patient engagement? Workshop on measuring the impact of pharmacovigilance activities 05-06 Dec 2016 Presented by Marin Banovac 06 December 2016 Patient reporting in the EU: Analysis of

587 views • 16 slides
COO Report to the Board For Reporting Month - March 2020 May 08, 2020 Patient Revenue

COO Report to the Board For Reporting Month - March 2020 May 08, 2020 Patient Revenue

COO Report to the Board For Reporting Month - March 2020 May 08, 2020 Patient Revenue Enhancement Strategy: Update 2 Patient Revenue Enhancement Strategy: Update * Ambulatory revenue impact assumes that 25% of volume are non-billable visits

437 views • 16 slides
Medical Event Reporting and Impact on Medical Licensee Patient Safety Culture Vasken Dilsizian,

Medical Event Reporting and Impact on Medical Licensee Patient Safety Culture Vasken Dilsizian,

Medical Event Reporting and Impact on Medical Licensee Patient Safety Culture Vasken Dilsizian, MD ACMUI Nuclear Cardiologist March 8, 2018 ME Reporting ME reporting has not changed significantly for many years. The annual number of

421 views • 20 slides
Direct Patient Reporting DPR: The Dutch case Fred de Koning London, june 17th 2011 I NTRODUCTI

Direct Patient Reporting DPR: The Dutch case Fred de Koning London, june 17th 2011 I NTRODUCTI

Direct Patient Reporting DPR: The Dutch case Fred de Koning London, june 17th 2011 I NTRODUCTI ON History Reasons for DPR? Reporting Direct Patient Reporting Feedback Facts & Figures 2 HI STORY REASONS

249 views • 22 slides
Evaluation of patient reporting to the Yellow Card System Professor Tony Avery University of

Evaluation of patient reporting to the Yellow Card System Professor Tony Avery University of

Evaluation of patient reporting to the Yellow Card System Professor Tony Avery University of Nottingham Background Patient reporting to the Yellow Card system began in October 2005 Evaluation funded by NIHR HTA and involved

527 views • 26 slides
Patient Care Update Patient Care Planning Group March 20, 2012 Tampa, Florida 1 Patient Care

Patient Care Update Patient Care Planning Group March 20, 2012 Tampa, Florida 1 Patient Care

Patient Care Update Patient Care Planning Group March 20, 2012 Tampa, Florida 1 Patient Care Update Grants/Funding Await Part B Award on April 1, 2012 for: Part B Base ADAP Earmark ADAP Supplemental Minority AIDS Initiative Emerging

596 views • 21 slides
EU Experiences w ith Patient Reporting Second Stakeholders Forum on the I m plem entation of the

EU Experiences w ith Patient Reporting Second Stakeholders Forum on the I m plem entation of the

EU Experiences w ith Patient Reporting Second Stakeholders Forum on the I m plem entation of the New Pharm acovigilance Legislation, London 1 7 June 2 0 1 1 Doris Irene Stenver, MD, MPA Chief Medical Officer, Consumer Safety Division EU

209 views • 16 slides
Federal For Hire Electronic Reporting Tab F, No. 5 Topics to Cover Update on Rules and

Federal For Hire Electronic Reporting Tab F, No. 5 Topics to Cover Update on Rules and

Federal For Hire Electronic Reporting Tab F, No. 5 Topics to Cover Update on Rules and Timelines Reporting Systems & Approvals NMFS VMS Reimbursement Program Questions from the Captains SEFHIER Support Update What we

227 views • 12 slides
Conversational Interfaces for Reporting Patient Safety Incidents: a Technical Feasibility and

Conversational Interfaces for Reporting Patient Safety Incidents: a Technical Feasibility and

Using Voice-Activated Conversational Interfaces for Reporting Patient Safety Incidents: a Technical Feasibility and Pilot Usability Study OWEN SUN JESSICA CHEN & FARAH MARABI 30 th July 2018 Centre for Health Informatics AUSTRALIAN

444 views • 19 slides
Additional monitoring of medicines and direct patient reporting impact on the package leaflet

Additional monitoring of medicines and direct patient reporting impact on the package leaflet

Additional monitoring of medicines and direct patient reporting impact on the package leaflet EMA Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) - 30 th November 2011 Deadline for com m ents: 2 0

338 views • 23 slides
COO Report to the Board January 2020 Patient Revenue Enhancement Strategy: Update 2 Patient

COO Report to the Board January 2020 Patient Revenue Enhancement Strategy: Update 2 Patient

COO Report to the Board January 2020 Patient Revenue Enhancement Strategy: Update 2 Patient Revenue Enhancement Strategy: Update * Ambulatory revenue impact assumes that 25% of volume are non-billable visits Initiative Strategy/ Update Vol

317 views • 16 slides
The UCLPartners Patient Safety Programme: Update Peter Toohey, Patient Safety Improvement Manager,

The UCLPartners Patient Safety Programme: Update Peter Toohey, Patient Safety Improvement Manager,

The UCLPartners Patient Safety Programme: Update Peter Toohey, Patient Safety Improvement Manager, UCLPartners #QIinAKI #QIinSepsis @UCLPartnersPSP @pete_toohey Patient Safety Priority Matrix Together, Sepsis & AKI account for two thirds

146 views • 10 slides
Tax & Financial Reporting Update Do You Really Understand What You Need to Know? W.P.A.S.G.L .

Tax & Financial Reporting Update Do You Really Understand What You Need to Know? W.P.A.S.G.L .

Tax & Financial Reporting Update Do You Really Understand What You Need to Know? W.P.A.S.G.L . Small Business Lending Conference March 13, 2014 A presentation by Donald S. Johnston and Mark Wolstoncroft IRS Circular 230 Notice To ensure

240 views • 20 slides
How CCAS benefits patient access and experience New clinical analysis reporting How

How CCAS benefits patient access and experience New clinical analysis reporting How

How CCAS benefits patient access and experience New clinical analysis reporting How CCAS benefits patient access and experience What Does CCAS Do? CCAS set up in 2007 Aim is to improve the quality of referrals in Camden and

364 views • 11 slides
FBAR and FATCA Update: Latest Foreign Account Reporting Developments Account Reporting Developments

FBAR and FATCA Update: Latest Foreign Account Reporting Developments Account Reporting Developments

Presenting a live 110 minute teleconference with interactive Q&A FBAR and FATCA Update: Latest Foreign Account Reporting Developments Account Reporting Developments New and Upcoming IRS Rules, First Form 8938 Filings, Upcoming FATCA Duties

888 views • 73 slides
Monthly Reporting Plan Data Entry Linking Other Features Division of Healthcare Quality

Monthly Reporting Plan Data Entry Linking Other Features Division of Healthcare Quality

Patient Safety Component Monthly Reporting Plan Data Entry Linking Other Features Division of Healthcare Quality Promotion Target Audience This training is designed for those who will enter patient, event and procedure information into

718 views • 69 slides
Reporting Adverse Events from Solicited Sources to the FDA EMA Workshop on Patient Support

Reporting Adverse Events from Solicited Sources to the FDA EMA Workshop on Patient Support

Reporting Adverse Events from Solicited Sources to the FDA EMA Workshop on Patient Support Programmes and Market Research Programmes June 7, 2013 Gerald Dal Pan, MD, MHS 1 FDA Regulations and Guidances There are no FDA regulations

109 views • 8 slides
Topics Current regulations and reporting of outbreaks Major changes to regulations

Topics Current regulations and reporting of outbreaks Major changes to regulations

Conference For Humbaugh 11/07/2014 Healthcare Transparency & Patient Safety 2 Topics Current regulations and reporting of outbreaks Major changes to regulations Definitions Simultaneous reporting of data to both National

348 views • 5 slides
Adverse Reaction (AR) Reporting and Patient Support Programmes/Market Research Programmes at

Adverse Reaction (AR) Reporting and Patient Support Programmes/Market Research Programmes at

Adverse Reaction (AR) Reporting and Patient Support Programmes/Market Research Programmes at Health Canada Dr. Christopher Turner National Visiting Expert in Pharmacovigilance Health Canada The views expressed in this presentation are the

103 views • 9 slides
Total Cost of Care Workgroup September 30, 2020 Agenda Update on Reporting Tools 1. Overview

Total Cost of Care Workgroup September 30, 2020 Agenda Update on Reporting Tools 1. Overview

Total Cost of Care Workgroup September 30, 2020 Agenda Update on Reporting Tools 1. Overview of the MPA Recommendation 2. Implications of the MPA Targets on utilization 3. SIHIS Goals on Care Transformation 4. 2 Update On Reporting Tools

751 views • 40 slides
Patient Radiation Dose Reporting (P-RDSR) Supplement is developed by DICOM Working Group 28

Patient Radiation Dose Reporting (P-RDSR) Supplement is developed by DICOM Working Group 28

Supplement 191: Patient Radiation Dose Reporting (P-RDSR) Supplement is developed by DICOM Working Group 28 (WG-28-Physics) Patient Radiation Dose SR (P-RDSR) Current Radiation Dose SR contains only information about the x-ray system or

180 views • 17 slides
LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? UC SF DIABETES UPDATE 2018

LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? UC SF DIABETES UPDATE 2018

DIABETES UPDATE 2018 LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? UC SF DIABETES UPDATE 2018 DISCLOSURES Educational grant from Cook Inc UC SF DIABETES UPDATE 2018 OBJECTIVES Review risk stratification and

695 views • 32 slides
Review of the Code of Accounting Practice and Financial Reporting (the Code) Update 28 2019-20

Review of the Code of Accounting Practice and Financial Reporting (the Code) Update 28 2019-20

Review of the Code of Accounting Practice and Financial Reporting (the Code) Update 28 2019-20 Welcome Introductions and purpose of the web video OLG Contents of this presentation Financial reporting governance structures and the Code

425 views • 41 slides
Implementation requires effective clinician-patient communication Nature 470:204, 2011

Implementation requires effective clinician-patient communication Nature 470:204, 2011

Panel 9: Patient-facing information tools, counseling/consent, reporting results to patients Steve Joffe, MD, MPH Vice Chair, Medical Ethics University of Pennsylvania William Lawrence Senior Program Officer, Communication and Dissemination

477 views • 33 slides

More recommend